Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
作者信息
Patel Chinmay, Yan Gan-Xin, Kocovic Dusan, Kowey Peter R
机构信息
Main Line Health Heart Center and Lankenau Hospital, Wynnewood, PA 19096, USA.
出版信息
Circ Arrhythm Electrophysiol. 2009 Dec;2(6):705-11; discussion 712. doi: 10.1161/CIRCEP.109.893628.
PMID:20009081
Abstract
摘要
相似文献
1
Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.导管消融术是否应成为减少植入式心律转复除颤器（ICD）电击的首选治疗方法？：室性心动过速消融与药物预防ICD电击：辅助抗心律失常药物治疗的作用
Circ Arrhythm Electrophysiol. 2009 Dec;2(6):705-11; discussion 712. doi: 10.1161/CIRCEP.109.893628.
2
Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.导管消融术应成为减少植入式心律转复除颤器（ICD）电击的首选治疗方法吗？：植入式除颤器患者的室性心动过速需要进行导管消融。
Circ Arrhythm Electrophysiol. 2009 Dec;2(6):713-20; discussion 720. doi: 10.1161/CIRCEP.109.896571.
3
Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.植入式心脏复律除颤器治疗与联用抗心律失常药物的必要性。
J Cardiovasc Pharmacol Ther. 2007 Sep;12(3):175-80. doi: 10.1177/1074248407305608.
4
[Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].[频发室性心动过速：抗心律失常药物治疗还是导管消融？]
Herz. 2005 Nov;30(7):613-8. doi: 10.1007/s00059-005-2749-7.
5
Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists.非电生理专业医生对植入式心脏复律除颤器患者的临床评估与管理
Circulation. 2004 Dec 21;110(25):3866-9. doi: 10.1161/01.CIR.0000149716.03295.7C.
6
Antiarrhythmic therapy for the prevention of sudden cardiac death.用于预防心源性猝死的抗心律失常治疗。
Can J Cardiol. 2000 Jun;16 Suppl C:29C-33C.
7
Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.结合减震策略增强 ICD 治疗效果：计算机建模的作用。
J Cardiovasc Electrophysiol. 2011 Mar;22(3):280-9. doi: 10.1111/j.1540-8167.2010.01918.x. Epub 2010 Oct 11.
8
Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?致心律失常性右室心肌病。抗心律失常药物、导管消融术还是植入式心律转复除颤器？
Herz. 2005 Mar;30(2):91-101. doi: 10.1007/s00059-005-2677-6.
9
Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure.心力衰竭患者室性心律失常和植入式心脏复律除颤器治疗的方法。
Curr Opin Cardiol. 2013 May;28(3):337-43. doi: 10.1097/HCO.0b013e3283604420.
10
Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.主要植入式心脏复律除颤器试验及《2006年室性心律失常患者管理和心脏性猝死预防指南》的应用。
J Cardiovasc Med (Hagerstown). 2007 May;8(5):320-3. doi: 10.2459/JCM.0b013e32816aa3ef.
引用本文的文献
1
Current and emerging antiarrhythmic drug therapy for ventricular tachycardia.当前及新出现的用于室性心动过速的抗心律失常药物治疗
Cardiol Ther. 2013 Jun;2(1):27-46. doi: 10.1007/s40119-013-0012-5. Epub 2013 Feb 20.
Zotero 插件